Metastases to the spine represent a challenging problem in an oncology practice. Treatment
decisions require multidisciplinary review. Radiation therapy remains the primary treatment …

With continued growth of the elderly population and improvements in cancer therapies, the
number of patients with symptomatic spinal metastases is likely to increase, and this is a …

Spinal metastases are a significant source of morbidity in patients with systemic cancer.
Roughly 30% of patients with cancer develop symptomatic spinal metastases during the …

Management of patients with spine tumors requires a multidisciplinary team that includes a
medical and radiation oncologist and a spine surgeon. Newer surgical techniques that …

Spine tumors may arise within or surrounding the spinal cord and/or vertebral column.
Spinal tumors can be benign or malignant. Based on their epicenter, they may be classified …

Introduction Management of metastatic spine disease is quite complex. Advances in
research have allowed surgeons and physicians to better provide chemotherapeutic agents …

Metastatic spinal tumors are the most common type of malignant lesions of the spine. Prompt
diagnosis and identification of the primary malignancy is crucial to overall treatment …

An improved understanding of tumor biology, the ability to target tumor drivers, and the
ability to harness the immune system have dramatically improved the expected survival of …

Metastatic spine disease accounts for 10% to 30% of new cancer diagnoses annually. The
most frequent presentation is axial pain. A thorough spinal examination includes …

Study Design: Literature review. Objective: To provide an overview of the recent advances in
spinal oncology, emphasizing the key role of the surgeon in the treatment of patients with …